Combined treatment with thalidomide, corticosteroids, and erythropoietin in patients with idiopathic myelofibrosis.
Benetatos
Leonidas
L
Leonidas
Benetatos
B
Chaidos
Aristeidis
A
Aristeidis
Chaidos
C
Alymara
Vasiliki
V
Vasiliki
Alymara
A
Vassou
Amalia
A
Amalia
Vassou
V
Bourantas
Konstantinos L
KL
Konstantinos
Bourantas L
BL
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D002675:Child, Preschool; D004359:Drug Therapy, Combination; D004921:Erythropoietin / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D055728:Primary Myelofibrosis / Q000150:complications / Q000188:drug therapy* / Q000209:etiology; D012074:Remission Induction / Q000379:methods; D013792:Thalidomide / Q000627:therapeutic use; D016896:Treatment Outcome
D000305:Adrenal Cortex Hormones; D004921:Erythropoietin; D013792:Thalidomide